Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04828954 · ClinicalTrials.gov registry record · NA
Variable Immobilization Protocol for Arthroplasty of the Carpometacarpal Joint of the Thumb
A NA study of Thumb Osteoarthritis, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT04828954: Recruiting NA study of Thumb Osteoarthritis, sponsored by University of Chicago.
NCT04828954 is a NA study of Thumb Osteoarthritis that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 90 participants, below the 104-participant average among 4 other Thumb Osteoarthritis trials with a reported enrollment target (13% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04828954, a NA study of Thumb Osteoarthritis, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Thumb carpometacarpal (CMC) osteoarthritis (OA) is common, seen frequently in middle-aged and elderly women. While a variety of surgical treatments have been described with none superior to any other, there is no consensus on the optimal duration of postoperative immobilization. Immobilization following surgery is critical for wound healing, pain control, and aid with activities of daily living in the early recovery period, though the duration of this must be weighed against the negative impacts of immobilization, such as stiffness, contracture, and delay in return to full function. The information gained in this study may allow hand surgeons to use an evidence-based postoperative rehabilitation protocol. Thus, our goal is to compare varying durations of postoperative immobilization after thumb CMC arthroplasty in a randomized trial design. Subjects will be randomized to treatment with non-removable thumb spica plaster postoperative splint immobilization for 2 weeks or non-removable thumb spica plaster splint transitioned to cast for a total of 6 weeks immobilization following base of thumb arthroplasty. Patient-reported outcome measures (PROs) and objective metrics will be tracked in the follow-up period.
Primary Outcome
The 11 question disability survey will be scored if at least 10 of the items are completed. The average score of responses (maximum of 5) will be obtained and transformed into score of 0 to 100 by subtracting one and multiplying by 25. A higher score indicated greater disability. The scores between treatment arms will be compared, as well as comparison of baseline scores with subsequent follow-up scores within each treatment arm. Administered at baseline visit, and 2-week, 6-week, 3-month and 1-
Conditions Studied
Interventions
- OTHER Immobilization for 2-weeks postoperative
- OTHER Immobilization for 6-weeks postoperative
Study Locations (1)
Illinois
- University of Chicago Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2026-08-04 |
| Phase | NA |
What NCT04828954 shows while recruiting
NCT04828954 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 104-participant average among 4 other Thumb Osteoarthritis trials with a reported enrollment target (13% lower).
The record links to 1 condition, with Thumb Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Immobilization for 2-weeks postoperative is the first listed.
NCT04828954 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04828954 about?
NCT04828954 is a clinical study titled "Variable Immobilization Protocol for Arthroplasty of the Carpometacarpal Joint of the Thumb". Thumb carpometacarpal (CMC) osteoarthritis (OA) is common, seen frequently in middle-aged and elderly women. While a variety of surgical treatments have been described with none superior to any other, there is no consensus on the optimal duration of postoperative immobilization. Immobilization follo...
What is the current status of trial NCT04828954?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2021-04-19. Estimated completion is 2026-08-04.
What conditions does trial NCT04828954 study?
This clinical trial studies the following conditions: Thumb Osteoarthritis.
What interventions are being tested in trial NCT04828954?
The interventions under investigation include: Immobilization for 2-weeks postoperative (OTHER), Immobilization for 6-weeks postoperative (OTHER).
Who is sponsoring clinical trial NCT04828954?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04828954 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thumb Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Turmeric for Patients With Basal Joint Arthritis
RECRUITING · NA
-
Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis
COMPLETED · NA
-
NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis
RECRUITING · Phase 3
-
Thumb Carpometacarpal Joint Denervation Versus Trapeziectomy
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI